Your browser doesn't support javascript.
loading
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Jiang, Tao; Chen, Jianhua; Xu, Xingxiang; Cheng, Ying; Chen, Gongyan; Pan, Yueyin; Fang, Yong; Wang, Qiming; Huang, Yunchao; Yao, Wenxiu; Wang, Rui; Li, Xingya; Zhang, Wei; Zhang, Yanjun; Hu, Sheng; Guo, Renhua; Shi, Jianhua; Wang, Zhiwu; Cao, Peiguo; Wang, Donglin; Fang, Jian; Luo, Hui; Geng, Yi; Xing, Chunyan; Lv, Dongqing; Zhang, Yiping; Yu, Junyan; Cang, Shundong; Zhang, Yaxi; Zhang, Jiao; Yang, Zeyu; Shi, Wei; Zou, Jianjun; Zhou, Caicun; Ren, Shengxiang.
Afiliación
  • Jiang T; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China.
  • Chen J; Hunan Cancer Hospital, Changsha, China.
  • Xu X; Northern Jiangsu People's Hospital, Yangzhou, China.
  • Cheng Y; Jilin Cancer Hospital, Changchun, China.
  • Chen G; Harbin Medical University Cancer Hospital, Harbin, China.
  • Pan Y; Anhui Provincial Hospital, Hefei, China.
  • Fang Y; Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Wang Q; Henan Cancer Hospital, Zhengzhou, China.
  • Huang Y; Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Centre, Kunming, China.
  • Yao W; Sichuan Provincial Cancer Hospital, Chengdu, China.
  • Wang R; Anhui Chest Hospital, Hefei, China.
  • Li X; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang W; The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhang Y; Shaanxi Provincial Cancer Hospital, Xi'an, China.
  • Hu S; Hubei Cancer Hospital, Wuhan, China.
  • Guo R; Jiangsu Province Hospital, Nanjing, China.
  • Shi J; LinYi Cancer Hospital, Linyi, China.
  • Wang Z; Tangshan People's Hospital, Tangshan, China.
  • Cao P; The Third Xiangya Hospital of Central South University, Changsha, China.
  • Wang D; Chongqing University Cancer Hospital, Chongqing, China.
  • Fang J; Beijing Cancer Hospital, Beijing, China.
  • Luo H; Jiangxi Cancer Hospital, Nanchang, China.
  • Geng Y; Baoji Central Hospital, Baoji, China.
  • Xing C; Jinan Central Hospital, Jinan, China.
  • Lv D; Taizhou Hospital of Zhejiang Province, Taizhou, China.
  • Zhang Y; Zhejiang Cancer Hospital, Hangzhou, China.
  • Yu J; Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
  • Cang S; Henan Provincial People's Hospital, Zhengzhou, China.
  • Zhang Y; Genecast Biotechnology Co., Ltd., Wuxi City, China.
  • Zhang J; Genecast Biotechnology Co., Ltd., Wuxi City, China.
  • Yang Z; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
  • Shi W; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
  • Zou J; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
  • Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China. caicunzhou_dr@163.com.
  • Ren S; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China. harry_ren@126.com.
Mol Cancer ; 21(1): 4, 2022 01 03.
Article en En | MEDLINE | ID: mdl-34980131

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Ácidos Nucleicos Libres de Células / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Ácidos Nucleicos Libres de Células / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China